Why so few get screened for lung cancer; Drug shortages' outsize impact on ovarian cancer patients

The lung cancer screening rate is just 5.7%, compared to 70%-75% for other tests like mammograms and colonoscopies.

August 18, 2023 Check out STAT+

Sponsored By

Adobe Why so few get screened for lung cancer, the deadliest cancer in the U.S. A combination of strict eligibility criteria and special coverage requirements means few at high risk get lung cancer screening. By Simar Bajaj Why drug shortages are having an outsize impact on ovarian cancer patients Ovarian cancer is relatively common, and the platinum-based drugs most effective in treating it are the ones in short supply. By Annalisa Merelli YouTube cracks down on misinformation on cancer treatment In the latest edition of STAT's Health Tech newsletter: YouTube on misinformation, machine learning gaps in medicine, and more. By Casey Ross

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser